Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06606574 · ClinicalTrials.gov registry record · NA

Intrathecal Baclofen and Pediatric Dystonia

A NA study of Dystonic Cerebral Palsy, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT06606574 is a NA study of Dystonic Cerebral Palsy that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06606574, a NA study of Dystonic Cerebral Palsy, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to better understand the effects of intrathecal baclofen (ITB) on children with dystonic cerebral palsy (CP). The main questions this study aims to answer are: (1) Determine if ITB reduces dystonia while identifying other potential benefits, (2) Identify the characteristics of children with the best response to ITB (3) Develop a holistically representative composite outcome measure for dystonic CP. This study will evaluate patient improvement by using a standardized titration, or medication management, protocol to gradually increase the childs ITB dosages over a 12-month period until they achieve maximum benefit with minimal to no side effects. This titration protocol mimics what is currently done through routine care but with more precision. This study will also directly measure the global effects of ITB, taking into account spasticity, known dystonia triggers (e.g. pain), and patterns of CNS injury that cause dystonia. Participants will: 1. Complete a total of 4 additional clinic visits outside usual care. These appointments will be with physical and occupational therapists as well as the study PI to complete evaluations for dystonia, spasticity, and function. 2. Complete several questionnaires at these visits. The total duration of the study for an individual child will be 12 months.

Conditions Studied

Interventions

  • OTHER Titration protocol

Study Locations (1)

Texas

  • Texas Childrens Hospital - Houston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2024-11-01
Est. Completion 2029-08-31
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT06606574

The ClinicalTrials.gov registry entry for NCT06606574 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dystonic Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Titration protocol is the first listed.

NCT06606574 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06606574 about?

NCT06606574 is a clinical study titled "Intrathecal Baclofen and Pediatric Dystonia". The goal of this clinical trial is to better understand the effects of intrathecal baclofen (ITB) on children with dystonic cerebral palsy (CP). The main questions this study aims to answer are: (1) Determine if ITB reduces dystonia while identifying other potential benefits, (2) Identify the char...

What is the current status of trial NCT06606574?

This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-11-01. Estimated completion is 2029-08-31.

What conditions does trial NCT06606574 study?

This clinical trial studies the following conditions: Dystonic Cerebral Palsy.

What interventions are being tested in trial NCT06606574?

The interventions under investigation include: Titration protocol (OTHER).

Who is sponsoring clinical trial NCT06606574?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06606574 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dystonic Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.